Oral Formulations for Macrocyclic Peptides & Linear GLP-1 Peptides

1:30 pm - Wednesday 29th April 2026

  • Highlighting the impact of gastrointestinal targeting
  • Improving oral bioavailability across the gut
  • Strategies to reduce negative food impact

NEW COMPANY

Speakers:

Founder & Chief Executive Officer
Cyprumed